INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

82,081 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
40
MZ
McIver ZachariahChief Medical Officer
JANXJanux Therapeutics, Inc.
Open-market sale
SELL$37K
2,714 sh
Jan 2, 2026Jan 2, 2026
Page 1782 of 2053
← PrevNext →
traded Jan 2, 2026
+0d
SEC Form 4

Evidence

39
CA
Campbell David AlanDirector, President and CEO
JANXJanux Therapeutics, Inc.
Open-market sale
SELL$111K
8,072 sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

39
MB
Manufacturers Life Insurance Co (Bermuda Branch)10% Owner
NANAJohn Hancock GA Mortgage Trust
Open-market purchase
BUY$5.00M
268.8K sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

38
Ehikian Stephen BradleyChief Executive Officer
AIC3.ai, Inc.
Open-market sale
SELL$3.19M
234.9K sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

36
DT
DiRaimondo ThomasChief Scientific Officer
JANXJanux Therapeutics, Inc.
Open-market sale
SELL$34K
2,505 sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

36
WM
Winter Charles M.Chief Technical Officer
JANXJanux Therapeutics, Inc.
Open-market sale
SELL$33K
2,401 sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

32
MH
Meyer Andrew HollmanChief Business Officer
JANXJanux Therapeutics, Inc.
Open-market sale
SELL$26K
1,879 sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

30
YS
Yoon SungSVP
KEYSKeysight Technologies, Inc.
Open-market sale
SELL$184K
889 sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

29
CH
Carson William H.Director
ANNXAnnexon, Inc.
Open-market purchase · 10b5-1 plan
BUY$21K
4,115 sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

28
BO
Blunt Christopher ODirector, Chief Executive Officer
FGF&G Annuities & Life, Inc.
Open-market purchase
BUY$148K
5,000 sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

27
MH
Milmoe William H.10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J$4.65M
120.0K sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

27
BE
Butler ErinPrincipal Accounting Officer
IMAImageneBio, Inc.
Grant or award
A—
22.5K sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

27
DD
DeSantis Deborah10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J$4.65M
120.0K sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

27
DD
DeSantis Dean10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J$4.65M
120.0K sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

27
KB
Klein Matthew B.Director, CHIEF EXECUTIVE OFFICER
PTCTPTC THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$620K
8,089 sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

26
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$2.80M
632.9K sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

24
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$2.77M
632.9K sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

23
SJ
Sahasi JayeshEV President, Product and CTO
ONTFON24 INC.
Open-market sale · 10b5-1 plan
SELL$277K
34.8K sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

23
MD
Metzfield DennisVP, PAO & Controller
BAHBooz Allen Hamilton Holding Corp
Grant or award
A—
1,175 sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

22
OW
Owens Donald WDirector, CEO, President and Secretary, 10% Owner
HNOIHNO International, Inc.
Gift
G—
450.0K sh
Nov 26, 2025Jan 2, 2026
traded Nov 26, 2025
+37dSEC Form 4

Evidence

22
MD
Maday DavidChief Financial Officer
AURAurora Innovation, Inc.
Gift
G—
79.9K sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

21
SH
Schatz Britta HarrisDirector
DGICADONEGAL GROUP INC
Grant or award
A$24K
1,200 sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

21
MH
Milmoe William H.10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J$4.65M
120.0K sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

21
RS
Ravella SatishChief Accounting Officer
ZETAZeta Global Holdings Corp.
Grant or award
A—
100.0K sh
Jan 1, 2026Jan 2, 2026
traded Jan 1, 2026
+1dSEC Form 4

Evidence

21
DD
DeSantis Dean10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J$4.65M
120.0K sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

21
MH
Milmoe William H.10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J$4.65M
120.0K sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

21
DD
DeSantis Deborah10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J$4.65M
120.0K sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

21
DN
Doyle Janeen NoelChief Corp. & Bus. Dev. Ofcr
JANXJanux Therapeutics, Inc.
Grant or award
A—
36.0K sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

21
DM
Dobek MariaVice President, Accounting
JANXJanux Therapeutics, Inc.
Grant or award
A—
18.9K sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

21
BN
Ballew NealCHIEF ACCOUNTING OFFICER
OHIOMEGA HEALTHCARE INVESTORS INC
Option exercise
M—
15.4K sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

21
GP
Gourmand Matthew PaulPresident
OHIOMEGA HEALTHCARE INVESTORS INC
Option exercise
M—
15.4K sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

21
DD
DeSantis Deborah10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J$4.65M
120.0K sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

21
MZ
McIver ZachariahChief Medical Officer
JANXJanux Therapeutics, Inc.
Grant or award
A—
29.0K sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

21
DD
DeSantis Dean10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J$4.65M
120.0K sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

20
BJ
Blackie JamesChief Revenue Officer
ONTFON24 INC.
Open-market sale · 10b5-1 plan
SELL$127K
16.0K sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

20
MM
Morral Peter M.Chief Development Officer
GPMTGranite Point Mortgage Trust Inc.
Tax withholding
F$74K
30.7K sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

19
MR
Mills Jason RichardDirector
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp
Grant or award
A—
7,758 sh
Dec 18, 2025Jan 2, 2026
traded Dec 18, 2025
+15dSEC Form 4

Evidence

19
SC
Shackley Brian CharlesChief Accounting Officer
AVAVAeroVironment Inc
Open-market sale · 10b5-1 plan
SELL$50K
200 sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

19
SS
Smith Maurice SDirector
HALHALLIBURTON CO
Grant or award
A—
1,212 sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

19
MR
Mills Jason RichardDirector
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp
Grant or award
A—
4,806 sh
Dec 18, 2025Jan 2, 2026
traded Dec 18, 2025
+15dSEC Form 4

Evidence